<DOC>
	<DOCNO>NCT01569503</DOCNO>
	<brief_summary>The purpose study determine whether ( VNS ) Vagus Nerve Stimulation , effective treatment Crohn 's disease .</brief_summary>
	<brief_title>Vagus Nerve Stimulation New Approach Treatment Crohn 's Disease</brief_title>
	<detailed_description>Inflammatory bowel disease IBD ( Crohn 's disease ulcerative colitis ) chronic inflammatory diseases involve digestive tract , particular small bowel and/or recto-colon . IBD represent public health problem Gastroenterology . The etiopathogeny IBD multifactorial involve immunological , genetic , infectious environmental factor . An overarching hypothesis unbalance autonomic nervous system , represent sympathetic parasympathetic nervous system ( e.g . vagus nerve ) part mechanism underlie pathophysiology IBD . A dysautonomia observe IBD patient recently demonstrate dysautonomia link psychological coping , particular Crohn 's disease . Classically , vagus nerve , mixed nerve , anti-inflammatory role central afferent secondarily stimulate hypothalamic-pituitary adrenal axis . Recent data show anti-inflammatory property vagus nerve also involve peripheral efferent via interaction acetylcholine nicotinic receptor lead inhibition TNF release macrophage . Vagus nerve stimulation ( VNS ) currently use treatment form epilepsy Human via stimulation vagal afferent . We recently validate model chronic VNS ( 3h/d 5 day ) freely move rat stimulate vagal efferent study anti-inflammatory property VNS experimental model colitis rat . VNS significantly decrease body weight loss due colitis anti-inflammatory effect decrease multivariate index inflammation . To date , medical treatment IBD ( e.g . 5-aminosalicylates , corticosteroid , immunosuppressive biotherapies i.e . anti-TNF ) suspensive . The aim project propose another type anti-inflammatory treatment base neurostimulation vagal efferent . For purpose , aim perform pilot study 10 patient moderate severe Crohn 's disease despite reference treatment ( corticosteroid and/or immunosuppressive ) use anti-inflammatory property VNS alternative anti-TNF therapy . Central peripheral effect VNS also evaluate electroencephalographic sympatho-vagal ( heart rate variability ) recording . The finality , term , use VNS alternative conventional anti-TNF therapy devoid side effect , particular infectious , advantage use intrinsic anti-inflammatory ( anti-TNF ) system take cover problem adherence treatment frequently observe medical treatment IBD .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Patients CD involve ileocolon , diagnose least 3 month prior screen flare ( 220 &lt; CDAI &lt; 450 ) disease despite treatment reference ( corticosteroid and/or immunosuppressive ) stable dose include CRP &gt; 5mg/l and/or fecal calprotectin &lt; 100Âµg/l CDEIS &gt; 7 ( Crohn 's disease endoscopic index severity ) Consenting patient Known cardiac pathology VNS contraindication Anoperineal CD associate ileocolic lesion Diagnosis indeterminate colitis , positive stool culture enteric pathogen CD Surgery within 3 month screen Short small intestine ( &lt; 1m ) Koenig syndrome Intraabdominal abscess Fistula clinical radiological abscess evidence Anoperineal CD without rectal involvement Ileostomy , colostomy , enteral parenteral feed Clinical condition medically surgically unstable , discretion investigator would compatible patient 's participation study Any recent neoplasia , year prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Crohn 's Disease</keyword>
	<keyword>VNS</keyword>
	<keyword>vagus nerve stimulation</keyword>
	<keyword>inflammation</keyword>
	<keyword>Inflammatory bowel disease</keyword>
	<keyword>TNF</keyword>
</DOC>